First report of CTX-M-14 producing clinical isolates of Salmonella serovar Typhimurium from Egypt.
Sameh M M
SM
AbdelGhani
Ellen Smith
ES
Moland
Jennifer A
JA
Black
Nancy D
ND
Hanson
Richard V
RV
Goering
Magdy A
MA
Amine
Amal E
AE
Saafan
Maha
M
Gaafar
Mariam
M
Younan
Kenneth S
KS
Thomson
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002648:Child; D024901:Drug Resistance, Multiple, Bacterial; D004534:Egypt / Q000453:epidemiology; D006801:Humans; D012480:Salmonella Infections / Q000201:enzymology / Q000453:epidemiology / Q000382:microbiology*; D012486:Salmonella typhimurium / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; C456080:beta-lactamase CTX-M-14; D001618:beta-Lactamases